Consortium Inc – Drug Abuse Rehabilitation Program is a nonprofit substance use treatment provider in Philadelphia, Pennsylvania, located at 451 South University Avenue. The Drug Abuse Rehabilitation Program program is operated by Consortium Inc.
Levels of care offered here include standard outpatient counseling, medication-assisted treatment (MAT), a federally certified opioid treatment program, co-occurring (dual diagnosis) mental health treatment, and telehealth therapy. Clinicians use approaches such as anger management, brief intervention, cognitive behavioral therapy, contingency management/motivational incentives, and community reinforcement plus vouchers. For opioid use disorder, the program uses methadone and buprenorphine.
Consortium Inc – Drug Abuse Rehabilitation Program accepts government funding for substance use treatment, Medicare, Medicaid, private health insurance, cash or self-payment, state-financed health insurance plan other than Medicaid, and SAMHSA funding/block grants. A sliding fee scale based on income is available. Coverage depends on your specific plan, so verify benefits before admission.
The program accepts young adults, adults, and seniors. It offers specialized groups for pregnant/postpartum women, seniors or older adults, veterans, and criminal justice (other than DUI/DWI)/Forensic clients.
Consortium Inc – Drug Abuse Rehabilitation Program is accredited by Commission on Accreditation of Rehabilitation Facilities (CARF) and licensed or certified by the state substance use treatment agency, state mental health department, and state department of health.
Support services include aftercare/continuing care, discharge planning, naloxone and overdose education, and outcome follow-up after discharge.